兔抗DCK多克隆抗體

Background:

Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

Applications:

ELISA, WB, IHC

Name of antibody:

DCK

Immunogen:

Fusion protein of human DCK

Full name:

deoxycytidine kinase

SwissProt:

P27707

ELISA Recommended dilution:

1000-2000

IHC positive control:

Human tonsil

IHC Recommend dilution:

25-100

WB Predicted band size:

31 kDa

WB Positive control:

Mouse heart tissue

WB Recommended dilution:

200-1000